Crossmark

Economic Evaluation of Budesonide Orodispersible Tablets for the Treatment of Eosinophilic Esophagitis: A Cost–Utility Analysis

Published Online: 2021-10-26

Published Print: 2021-12

Authors

Beauchemin, C. https://orcid.org/0000-0002-5903-5430
Castonguay, A.

Chan, E. S.

Dellon, E. S.

Feagan, B. G.

Ma, C.

Waserman, S.

Cook, J.

Claveau, D.
Funding

Funding for this research was provided by:

avir pharma inc.
License Information

Text and Data Mining valid from 2021-10-26

Version of Record valid from 2021-10-26
More Information

Article History

Received: 26 August 2021

Accepted: 8 October 2021

First Online: 26 October 2021

Document is current